These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 9059333

  • 21. Prognostic value of angiogenesis in gastro-intestinal tumours.
    Chung YS, Maeda K, Sowa M.
    Eur J Cancer; 1996 Dec; 32A(14):2501-5. PubMed ID: 9059339
    [No Abstract] [Full Text] [Related]

  • 22. Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment.
    Fidler IJ.
    J Natl Cancer Inst; 2001 Jul 18; 93(14):1040-1. PubMed ID: 11459857
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Carbohydrate-recognition and angiogenesis.
    Nangia-Makker P, Baccarini S, Raz A.
    Cancer Metastasis Rev; 2000 Jul 18; 19(1-2):51-7. PubMed ID: 11191063
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy.
    Favard C, Ortega N, Bayard F, Plouet J.
    Diabetes Metab; 1996 Jul 18; 22(4):268-73. PubMed ID: 8767174
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. VEGF and tumour angiogenesis. Impact of surgery, wound healing, inflammation and blood transfusion.
    Svendsen MN, Werther K, Nielsen HJ, Kristjansen PE.
    Scand J Gastroenterol; 2002 Apr 18; 37(4):373-9. PubMed ID: 11989825
    [No Abstract] [Full Text] [Related]

  • 31. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
    Rogala E, Skopińska-Rózewska E, Sommer E, Pastewka K, Chorostowska-Wynimko J, Sokolnicka I, Kazoń M.
    Anticancer Res; 2001 Apr 18; 21(6B):4259-63. PubMed ID: 11908679
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The role of vascular cell integrins alpha v beta 3 and alpha v beta 5 in angiogenesis.
    Varner JA.
    EXS; 1997 Apr 18; 79():361-90. PubMed ID: 9002227
    [No Abstract] [Full Text] [Related]

  • 35. Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena.
    Iozzo RV, San Antonio JD.
    J Clin Invest; 2001 Aug 18; 108(3):349-55. PubMed ID: 11489925
    [No Abstract] [Full Text] [Related]

  • 36. Vascular endothelial growth factor as a target for antiangiogenic therapy.
    Gordon MS.
    J Clin Oncol; 2000 Nov 01; 18(21 Suppl):45S-6S. PubMed ID: 11060326
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Tumor angiogenesis].
    Bussolino F.
    Recenti Prog Med; 1999 Jan 01; 90(1):28-36. PubMed ID: 10193163
    [Abstract] [Full Text] [Related]

  • 40. [Angiogenesis and tumor growth. Angiogenic factors and tumor growth].
    Plouet J.
    Ann Pathol; 1999 Jan 01; 19(5 Suppl):S70-1. PubMed ID: 10599456
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.